General discussion, page-11517

First 11517 Last

Share
Profile

Follow
Paulfool

1,273 Posts.

739

24/01/22

11:41

Post #: 59086004
Share

Originally posted by thevinnys: ↑

Regarding OSA - Surely I am not the only one that can see an alignment/pivot based on foundations of success?

Action A. Open-Label Extension Study - Not required if negative results
Action B. Using Data from Alfred Trial to support the International Patent Application - Not required if Negative Results
Action C. Additional Study at UWA - Not required if Negative Results
Action D. Dual Locations studies for further evidence to advance FDA approval - Not required if Negative Results
Action E. Preparation of PRE-IND FDA meeting package with aim of a meeting with FDA for Q1, 2022. - Not Required if Negative Results
Action F Listing on the NASDAQ to coincide with the release of results from our IHL-42X - Not required to coincide, NASDAQ Listing, if Negative
Action G Appoint New York Based PR firm to represent/arrange for Medical Conferences - Not Required if Negative Results
Action H Setup USA Office strategic stakeholder engagement with clinical research facilitators, regulatory authorities, and the investment
community - Not Required if Negative Results.
Action I CEO move to USA to set up our US office and networks - Not Required if Negative Results
Price fluctuations will always be here.

Just need patience for the prices to re-align with the business

GLAH

Expand

@thevinnys this one is also good, as its all about mental reference points and what time horizon you look at.

Time away from focusing on SP helps, but I need to sail a bit further to be out of wifi range.

IHL Price at posting: 50.0¢ Sentiment: Buy Disclosure: Held
17 Upvote

0 Great analysis

Reply

Top Stories

CHN

Chalice jumps on Putin nickel export ban threat – but then there's bad news

3 stocks with antimony news on Thursday

BRX

Belararox to grow copper footprint in Botswana with 4,286 square km tenure

ASX Market Open: Local bourse to trade green | Thursday September 12

NEC

Nine Entertainment announces its CEO is stepping down – on an ex-divvy day

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3

SS1

Sun Silver confirms high-grade extension theory at Maverick Springs with 79.6 g/t intercept

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

CU6

Clarity progresses SECuRE trial with positive safety results

MTM

Forget gallium: MTM says it's extracted gold from e-waste